Sonia Prashar 0:02 What stuck with me the most was, especially, like, twelve years back, I would say, after my kids were born, I suffer from postpartum myself, not realizing I had it. Having that stigma of not being able to talk about it because of the South Asian stigma, especially, it made me realize we need to have advocates. We need to talk more about it because there's nobody talking about it.
Brandon Li 0:27 Welcome to Power to the Patients. I'm Brandon Lee. And today, I'm joined by Sonia Bershar, the founder and CEO of AIM trials. Sonia has over eighteen years of clinical research experience focusing largely on mental health in both pediatric and adult populations. She's also a passionate advocate for breaking the stigma around mental health, and her team is pioneering a lot of really innovative research techniques across AI and DCT decentralized models in order to expand patient access and improve outcomes. So, Sonya, welcome to the show.
Sonia Prashar 0:56 Thank you so much, Brandon. Thank you for with power.
Brandon Li 0:59 That's too kind. But today is not about us. Today is about you. Before we get into the nuts and bolts of what AIM is today, I'd love to hear what inspired you. How did you get into research in the first place?
Sonia Prashar 1:08 So research in the first place happened eighteen plus years ago, thanks to my PhD professor at that time, who did not think I was the right fit to be in the lab. And clinical research was not something that people knew back then at all. It was the three part paper CRX. And Mark, at that time, needed CRAs to work for urology and oncology. It was during the spring break time. He just said, well, why don't you try this and then see if you like it? And I got pushed into the world or inspired, gently nudged, whatever you can say, into the world of clinical research, and I never looked back.
Brandon Li 1:45 So something must have stuck for you then when you got nudged in there. What was it that really took hold?
Sonia Prashar 1:50 What really took hold, very good question, is seeing the results. Understanding research isn't just about being in the lab, looking things through the microscope. When clinical research industry is a different type of research, I'm a person who is my personality fit through talking to the patients, involving myself with the community, and getting the positive feedback and realizing, wow, this is such an important work that I am doing beyond the lab, that just stuck with me.
Brandon Li 2:23 Is it certainly, so many, I think, of the the powerful stories we hear come from the day to day work with the individuals who choose to participate in the research, and they're really the heroes in all of it.
Sonia Prashar 2:35 110%. You get the real time feedback, and you realize this is why we are doing this.
Brandon Li 2:40 And psychiatry research? Like, how did that happen? from the day to day work with the individuals who choose to participate in the research, and they're really the heroes in all of it.
Sonia Prashar 2:35 110%. You get the real time feedback, and you realize this is why we are doing this.
Brandon Li 2:40 And psychiatry research? Like, how did that happen?
Sonia Prashar 2:43 So I tried different types of clinical research, I'll be honest, like, from dermatology to I was actually including cardiothoracic, TAVR procedures, including AFib procedures, EP, everything. In and out, I would come back and forth between mental health. What stuck with me the most was, especially, like, twelve years back, I would say, after my kids were born, I suffer from postpartum myself, not realizing I had it. Having that stigma of not being able to talk about it because of the South Asian stigma, especially, it made me realize we need to have advocates. We need to talk more about it because there is nobody talking about it. And I think it was around my kids were around three years of age or something, and I just had an opening and opportunity to just get back into research again and because I'd taken a little break at that point, jump back into research and into mental health with intent that I do wanna talk about mental health, the stigma associated and surrounded with it. And there's so much research that still needs to happen, especially in pediatric. There are so many different types of like, postpartum being one of those. Our communities need to know that it's okay to talk about this, and help is needed.
Brandon Li 4:02 Sure. Which is maybe a nice, I think, transition into AIM trials. Tell me a little bit more about the work you're doing.
Sonia Prashar 4:08 So at AIM trials, we are a research site. We work not exclusively in mental health, but about 80% we are into mental health, pediatric adults, geriatric. We have investigators who are board certified in psychiatry, PhD psychologists, nurse practitioners, mental health nurse practitioners as well, psychedelics including. And one of the biggest, I would say, for anybody who comes and visits AM trials, one of the biggest takeaway message would be everybody there is very passionate and compassionate, both. Passionate towards research, passionate towards the topic of mental health, wanting to break the stigma, but compassionate towards the patient care, understanding the patient is the center of it all.
Brandon Li 4:53 I think running in this space, working across psychiatry research, it's obvious that it's certainly not an easy field to do research in. What have you found to be critical to doing great research in psychiatry?
Sonia Prashar 5:07 Keeping the patient in the center and the focus. I know with technology advancements that are happening, people talk about AI day in, day out. Especially these days, there's more about it, especially with the chat GPD open AI and everything. The critical aspect in mental health research is connecting with that person across sitting across from you, understanding where they're coming from and putting things into their perspective. alk about AI day in, day out. Especially these days, there's more about it, especially with the chat GPD open AI and everything. The critical aspect in mental health research is connecting with that person across sitting across from you, understanding where they're coming from and putting things into their perspective.
Brandon Li 5:35 Let me be a little bit difficult. I think that in some of the conversations we've had with, uh, with CMOs, uh, they'll say that one of the hard things about psychiatry research is that the placebo effect is so strong, especially in a setting where building a relationship with somebody with severe depression or anxiety in a research setting can actually contribute to improvement in symptoms. So I totally understand the desire to want to build that kind of empathetic experience for the individual. But then how do you balance that with trying to keep clean clinical, like, separation?
Sonia Prashar 6:05 So with clinical separation, it's about making sure when your patient walks in, like you just talked about anxiety. I'll give you a very good example. So we had a patient for, actually, one of the studies that, I guess, we all are working on together on. We can't say which right now, but or we can. I don't know. But so he walks in, reads the consent, everything, understanding there's a placebo effect to it. And it is important at that point of time to deliberately sit through and make them understand, like, hey. You're not here to please me. And that's where I'm talking about connecting with them. So you cannot really take away the clinical care part of it, or you can just substitute it with making them understand like, hey. You're not here to please me. This is for you. And if you are not able to tell me what's going on, we won't be able to bridge that gap. So making sure you understand where this person's perspective falls into where they're coming from. And at the end of the day, it's a detailed informed consent. It is not easy, but somebody's got to bridge that gap.
Brandon Li 7:08 I think that a a lot of folks would say that you've operated through a a really exciting time in psychiatry research, let's say, over the last the good time, last ten years. How have you seen the landscape evolve, like, in those ten years? What's new? Where where were things before? ge that gap. I think that a a lot of folks would say that you've operated through a a really exciting time in psychiatry research, let's say, over the last the good time, last ten years. How have you seen the landscape evolve, like, in those ten years? What's new? Where where were things before?
Sonia Prashar 7:28 A lot has changed in last ten years. So much. So much. We're talking simple things, right, in our personal lives too, things that we growing up didn't have, which is social media. Let's talk about that putting it into personal perspective. Today's kids or today's new adults, young adults, have to deal with the anxiety of, oh my god, somebody's putting this on social media. Mental health itself has changed. A person's perspective post COVID changed. So the landscape changed so much with all these added technologies, the peer pressure, the expectations that research had to adapt to it. The use of marijuana increased. Are we accepting that? How do we now mitigate that situation? With then we talk about contraception. That landscape has changed where we are seeing a lot of now new protocols adding the use of oral contraceptive, which wasn't the case in ten years ago because there were not that many. So research in general has changed. Mental health research has changed even more, keeping in mind the situations around us, including COVID. And protocols, like you said, 10 ago, were sweeter the times, and now it's just getting tougher and tougher.
Brandon Li 8:48 Well, it seems to be the arc of research that it gets tougher and tougher. Look at oncology and the way that work is getting done now.
Sonia Prashar 8:54 I stepped away from oncology so many years ago. I tried back going up, and I just couldn't because, again, like you just said, it's the landscape's changing everywhere. The expectations are changing. And, of course, the guidelines are getting stricter, which they should because it's adaptability at the end of the day. And we have to basically be relevant in some way or the other now.
Brandon Li 9:15 Absolutely. Maybe kind of like changing gears. So things have changed a while or changed a lot over the last ten years. What do you think that sponsors don't quite get right today in this climate of how research is happening today? d we have to basically be relevant in some way or the other now. Absolutely. Maybe kind of like changing gears. So things have changed a while or changed a lot over the last ten years. What do you think that sponsors don't quite get right today in this climate of how research is happening today?
Sonia Prashar 9:28 Hybrid models. We talk so much about decentralized trials. We talk so much about, oh, wow. You know, decentralized trials are gonna be game changer. Everything's said and done. Technology's gone so far, but research has not adapted technology to its fullest. Research has not yet come to terms with it. Today's if you look at it as a society, people are busy compared to what they were ten years ago working. Both parents are working now in case of pediatrics. Right? Hybrid models or decentralized trials are still not implemented like they should be. We talk about, oh, AI is taking over. But have we, as a research group, actually implemented those? And sponsors are still hesitant, but I think they need to start implementing that because that will not only reduce the burden on the patients, but also the site staff. You're getting real time data. And that's when, at the end of the day, the technology is gonna go over.
Brandon Li 10:25 This is so interesting to me. So talk to me about let's design a protocol from scratch, actually. Let's design a protocol. How would you like to see hybrid techniques used in a prototypical, like, uh, depression study, an MDD study? Like, where should it go? day, the technology is gonna go over. This is so interesting to me. So talk to me about let's design a protocol from scratch, actually. Let's design a protocol. How would you like to see hybrid techniques used in a prototypical, like, uh, depression study, an MDD study? Like, where should it go?
Sonia Prashar 10:38 I'd love that. Let's take into example just a depression 18 through 65 years of age. Three months study. Let's assume total of maybe 14 visits. Let's have patient come in for screening visit. Paperwork, everything, blood work, ECG easily can be done on-site. Split the screening visit into two. Allow the patient to have the remote one on one with the psychologist or the psychiatrist or the investigator at site, the PI, remotely, reducing that burden. Now you're not asking the patient to come to site for spending three hours straight. You're telling them, hey. I need you to come just for an hour and a half. We're gonna do the initial screening of intake, consent, medical history review, everything, EKG, blood work, vital signs. Let me get all of that information, schedule a second screening part, which is a hybrid model where you're seeing the patient over the phone via Zoom, telehealth, or your rating scales, your psyche about with the investigator. You're automatically talking retention here. Interest is increased. Once you qualify, let's have you come in for randomization visits. So I'll explain to you how this how to take the medication, everything. You have now most of the protocols implementing third party apps on patient compliance. I will see you back now in a month. Between that, your medication dispensing will be done through a third party courier. They'll do a home health visit to dispense the medication. We'll be seeing you at in that one month period, I'll still see you, or our doctor will continue to see you weekly for the rating scales via Zoom, and the link will be sent to you. We'll review your compliance on the third party app to make sure you are really taking the medication like you're supposed to. Again, we've reduced the burden on the patient to come weekly. We'll reduce the burden from the patient about taking time off of work, and your retention has now increased by tenfold. I'm not having to take time off.
Brandon Li 12:41 Totally. This all makes tremendous sense to me. Why not? Like, uh, if we're gonna steel man this, like, why not do it this way? o come weekly. We'll reduce the burden from the patient about taking time off of work, and your retention has now increased by tenfold. I'm not having to take time off. Totally. This all makes tremendous sense to me. Why not? Like, uh, if we're gonna steel man this, like, why not do it this way?
Sonia Prashar 12:47 That's a good point. Why not do it? So FDA actually released guidance about use of AI in research in just January 2025, which which shows their flexibility. They're ready to adapt AI, but sponsors are still hesitant. Is it because the technology just isn't available? Is it because of the cost? That remains a question. But at the same time, on the site level, if you're looking at it, I'm on the operations ground level here. I hear these stories from patients firsthand. Like, I can't take time off. You're the great patient. I know he this is a great candidate for the study, meets all the criteria. They can't just come in that often. Psychedelic studies and if we can do the prep sessions, the integration sessions remotely, we're automatically reducing the burden from the patients. Because it's a lot to ask, especially now that people are having to go back to work full time with the economy is layoffs are happening everywhere, inflation's on the rise. We need good patience, but we also need to understand, hey. This is real world.
Brandon Li 13:53 I think especially in psychiatry where the scales are can be done remotely, it can make a lot of sense. Like, surely, there's something that sponsors are scared of when they design this research.
Sonia Prashar 14:05 I'm curious, as curious as you are, because I think where I stand today, I love embracing technology. I really do love embracing technology because it should be used to augment. It's not replacing the human connection or anything. It's here to empower us. And if we are able to do so, then why not?
Brandon Li 14:24 I guess the only the only argument that I think ends up circulating in my head is, is there for some reason a hypothesis that the data might not be as clean? Like, we were talking about the placebo fact and how in psychiatry it's, like, particularly difficult. Is there, like, for some reason that it'll make it harder to separate? only the only argument that I think ends up circulating in my head is, is there for some reason a hypothesis that the data might not be as clean? Like, we were talking about the placebo fact and how in psychiatry it's, like, particularly difficult. Is there, like, for some reason that it'll make it harder to separate?
Sonia Prashar 14:43 I really don't think so because we're using technology to bridge that gap between which we're talking about gap as in augmenting. We're in empowering this patient to be even more receptive. Retention is because at the end of the day, it's about data. It's a cleaner data. I also have a counterargument to that for certain studies where I'm having a patient to come to my clinic for a visit, but this patient just had a hard day at work because they had to leave work to come here for traffic forty minute. When I'm sitting front in front, they are also keeping in mind they just had to sit in traffic for forty hours. Their blood pressure's up. Basically, not in the frame of mind because they are just still going over and over about what happened in forty minutes of that traffic. So but at the same time, when they're sitting across on a Zoom camera, they are much more present. They're much more present in the moment. They're able to give much more cleaner information and or we're not worried about, oh, is this are you talking about the forty minutes of traffic that you had? Like, is it influencing your information? The patient's much more at their comfort, especially anxiety studies if we talk about.
Brandon Li 15:56 Totally. There's an interesting argument to be made that actually having more remote data or, like, hybrid data kind of, like, capture is a more authentic view of the the kind of individual experience because it's, like, in their day to day as opposed to in a, uh, contrived setting almost? bout. Totally. There's an interesting argument to be made that actually having more remote data or, like, hybrid data kind of, like, capture is a more authentic view of the the kind of individual experience because it's, like, in their day to day as opposed to in a, uh, contrived setting almost?
Sonia Prashar 16:14 Well, and in certain cases, we're also reducing the burden on the families because there are caregivers who are having to come, but it's not the caregiver who's the patient, but they are having to take time off. And we have to take into consideration when we're building the protocol. And, like, we did a study while back for a very rare disease for Duchenne's muscular dystrophy. And it was a complete decentralized trial on adolescents. And we saw about 60% increase in recruitment, 100% retention. Everything was done remote, including sending medications, everything, because that improved accessibility for patients and the caregivers with remote monitoring visits and wearable devices and everything with home visits included, that also increased diversity. We're talking patients from we want diversity in our trials. With hybrid models or decentralized models, we are now actually able to reach the rural where these patients probably it's inconvenient for them to come to these centers and not take research to them. And I was talking to Canadian embassy folks right here in Dallas. So one of them actually was from their health care ministry. So he and I had a meeting, and they want to see how we can help them build a protocol for rural population in Canada, take research to them because they don't have accessible transportation, especially in winters. Accessible transportation to come to metro cities. How can we basically like, we're helping them build a protocol just around decentralized trials.
Brandon Li 17:53 It's interesting to hear that, you know, you're kind of plugging into the rural Canadian challenge. It is just as big a challenge in The US, engaging rural populations, especially with mental health.
Sonia Prashar 18:04 Absolutely. Across the globe. And I think mental health is one such area where remote hybrid decentralized trials can be easily implemented.
Brandon Li 18:13 So let me be difficult again. Um, this is the theme of the podcast. We talk about something and then I, uh, um, and then I steel man it. Do we strictly need to increase access in research specifically to rural populations, or can the research be sufficiently done with folks who have direct access already to like, is there a research imperative that requires us to engage with those folks? talk about something and then I, uh, um, and then I steel man it. Do we strictly need to increase access in research specifically to rural populations, or can the research be sufficiently done with folks who have direct access already to like, is there a research imperative that requires us to engage with those folks?
Sonia Prashar 18:40 Absolutely. It's needed. When you talk about brick and mortar, you're talking about patients coming to me. We're talking diversity. 2024 FDA's regulations wants more diversity. In a metro city, even such as DFW, Dallas Fort Worth, we have so many different research sites. There's thousands of people coming in day in, day out. But what about the ones who live two hours away, have no accessibility around them, and that's a big town. It's a large population. What about them? We need diversity. We need to start going to them. We can't expect everybody to come to us. It has to be two way street here when also you're talking about Texas in general. It's such a big state.
Brandon Li 19:24 I guess, like, the the thrust of the question is, hey. This study is looking for 200 participants, 500 participants. Surely, there are 500 participants within a 20 mile catchment area of the research sites.
Sonia Prashar 19:37 But also those 500 patients, think about those 500 patients who are we're talking about. I'm we're talking about a certain mile radius, certain mile radius from the brick and mortar site. It could be saturated with only one ethnic group or two or three ethnic groups. We're not talking about the other ethnic groups that are outside of that radius of the brick and mortar site. So those 500 patients cannot be just simply be 60% of one ethnic group, 20% of one ethnic group. If we want data, a true clean data, we also want this medication to work, like, genetically speaking, on different ethnic groups. We have to spread that mileage that radius from the brick and mortar site. But we certainly can't expect this person from rural to come here two, three hours away, leaving their job every fifteen days. But also when I talk to one person from that ethnic group who recommends another person, I'm slowly increasing my pool.
Brandon Li 20:38 So you're clearly passionate about the use of this technology and research. It must be frustrating, I guess, as a site because the decision making around the use of these tools happens with the sponsors. How do you try to make the change that you you want to see?
Sonia Prashar 20:52 I think you know it well. I'm very vocal.
Brandon Li 20:55 Sure. Yeah. Yeah. You have to be. arch. It must be frustrating, I guess, as a site because the decision making around the use of these tools happens with the sponsors. How do you try to make the change that you you want to see?
Sonia Prashar 20:52 I think you know it well. I'm very vocal.
Brandon Li 20:55 Sure. Yeah. Yeah. You have to be.
Sonia Prashar 20:57 Pressing to hide. So every opportunity that I have, I'm the first person to say, hey. We need this. Because like anything else, like I told you when my own story with postpartum, I realized when I was going through it, there was nobody talking about it. I said, you know what? I have to talk. I don't talk about it, then for the change to happen, we have to be the change. We have to talk about it. It's not going to be overnight. It's not going to be overnight, but there could be somebody who is in the similar boat or in the same process as me, but just as afraid to talk about it because of the repercussions. But I want to talk about it because if I don't give the real feedback to the sponsors, they're never going to understand the real operational challenges on the ground. So every opportunity that I get to meet with any medical director, CEOs, anybody, I'm very vocal about it. Be it budget, be it implementation of technology, be it implementation of hybrid models, home health visits, I'm very vocal about it because the feedback is important.
Brandon Li 22:01 I guess the you would know better than me, but kind of frustrating reality of adopting innovation in this space is that it kind of has to start in phase one or phase two. Otherwise, it never like, otherwise, nobody wants to do the brand new thing on phase three.
Sonia Prashar 22:13 I agree. But you and I know it better that's on the sponsor ends, things are a completely different ballgame. Like, I've come from a sponsor side, and I understand the vendor's situation. And that's where I'm going back. Do we just not have the technology? Like because I look at other industries and I realize, wait a minute. Look at how the technology advancement and adaptability is. Why are we so behind?
Brandon Li 22:36 I get asked that all the time.
Sonia Prashar 22:38 And what is stopping us?
Brandon Li 22:40 I have an opinion, but I'm curious if you have an opinion.
Sonia Prashar 22:42 What is yours? Let's start with that. technology advancement and adaptability is. Why are we so behind?
Brandon Li 22:36 I get asked that all the time.
Sonia Prashar 22:38 And what is stopping us?
Brandon Li 22:40 I have an opinion, but I'm curious if you have an opinion.
Sonia Prashar 22:42 What is yours? Let's start with that.
Brandon Li 22:44 My opinion is that the nature of clinical research requires things to be very stable for long amounts of time in order to have clean data and clean research. You're gonna run a study for two or three years, and you actually want the conditions in your month one to be the same conditions as month 24. And as a result, it is a lot harder, I think, for folks to iterate quickly. The iteration cycles on techniques and technology take a year or two because of the nature of needing similar conditions. Whereas in a lot of other spaces, you could build a new product next month and try it out. Or, god forbid, on social media, you can build a new product tomorrow, and and then millions of people will get to try it. Whereas because research requires similar conditions in month one and month 18, the speed of iteration takes a lot longer. And then as a result, we can't have to fall off this quickly. At least that's my take.
Sonia Prashar 23:39 I personally feel it's a lack of knowledge. It's not so much of because if you look at it on the ground level, we just came out of COVID, like, few years ago. Things changed overnight. Business was as usual after a few months. People were research of course, some of it stopped, but some
Brandon Li 23:55 of it : I personally feel it's a lack of knowledge. It's not so much of because if you look at it on the ground level, we just came out of COVID, like, few years ago. Things changed overnight. Business was as usual after a few months. People were research of course, some of it stopped, but some of it
Sonia Prashar 23:55 continued. Problem was nobody knew what to do because of the lack of knowledge of adaptability towards the technology. Human, in general, if you look at it, we adapt to things faster. That's the whole thing. Right? We adapt. What you're talking about manufacturing standpoint, I get it. It has to be consistent environment, consistent things. But when we're talking about humans and mental health, it's never going to be this. It's like an EKG graph up and down. Mood swings are going to be there. When you take a bipolar patient specifically or schizophrenia patient, you are probably at a better chance of doing a hybrid model where if a patient's having a mental health crisis, instead of burdening the patient to come to the visit, burdening the site to constantly having to follow-up with this patient saying, hey. I need you to come. Reminder. Reminder. This patient's already in crisis at this moment. This patient does not need to be burdened with more. We need to adapt to do home health. Give us that option. If you can implement 100%, put that as an option saying, hey. In cases like this, Sykes can go to the patient. Home health is an option. Hybrid is an option. You're now not having a patient who's saying, I'm not coming back to your site. I don't want to come. You've lost this data completely. Sometimes six months worth of data wasted because this patient early terminated because of that one moment. It is 100% frustrating for everybody. But now you want to implement this, give them that chance. Let's work together. But it's the lack of knowledge of how to do this or implement it is what stops us, is the fear.
Brandon Li 25:38 I think it's the fear. Right? Because at the end of the day, this this whole apparatus stops and starts at FDA approval.
Sonia Prashar 25:46 But now, hopefully, with the new 2025, I've read it, and I like it. I it just shows how FDA too is ready to adapt, and they're flexible.
Brandon Li 25:56 And I've had, uh, conversations with a lot of regulators who, uh, I think are always, like, frustrated that they're seen as this boogeyman. Right? They're like, they're seen as the boogeyman, but, like, no. They're not trying to stop research. Uh, they're they're trying to adapt to the moment as well while maintaining, I think, the the level of scientific record that's necessary.
Sonia Prashar 26:15 Absolutely. At the end of the day, we are all here for the same thing is, pay keeping patient in the center of it all, not losing the touch, keeping recruitment as diverse as possible, making sure retention is higher, but without burdening anybody here, getting the cleaner data, and making sure it's quality that everybody gets. y. At the end of the day, we are all here for the same thing is, pay keeping patient in the center of it all, not losing the touch, keeping recruitment as diverse as possible, making sure retention is higher, but without burdening anybody here, getting the cleaner data, and making sure it's quality that everybody gets.
Brandon Li 26:38 Of course. At the end of the day, if we do all those things, then we get to participate in this beautiful mission of conducting medical research and bringing life changing treatment options to to others. And that's kind of why we all wake up in the morning.
Sonia Prashar 26:53 That's exactly why. And if we can do it, why not? Like, when we did with the DMD study, the must the Duchenne study, it was impressive, Brandon. It was really impressive because it talked about like, we were able to capture real time data with the variable device. We were able to capture real time data which we would have not been able to. And it was minimizing disruption in day to day life for parents and the children, financial liabilities, even coming going, like, the whole thing. It was flexible. In fact, we were able to capture more data, which further led to development of the second protocol.
Brandon Li 27:31 It's the classic standing on the shoulders of giants. Right? All research kind of builds on the the research that comes before.
Sonia Prashar 27:37 Oh, absolutely. Viagra is the classic example here, like everybody says.
Brandon Li 27:42 This has been so fun. I wanna close with a a slight change of topic, which is that you've been successful doing something that's really hard, which is building your research site. What do you wish you knew ten years ago when you decided to embark on this?
Sonia Prashar 27:56 I wish I knew it was this hard. I really didn't know. I mean, if I have to tell myself that sitting across the room and thinking I can start seemed easy. It sounded easy. It but actually doing it, I realized it, it's way more harder Way more harder because I don't think people understand the sacrifices that go beyond building anything. Like, you have started with power. You know it is not easy and constantly trying to be relevant. When there is so much noise around, there's so much competition around, how do you stay relevant? How do you always ahead of the curve in mind, but keeping your own mental health in check as well?
Brandon Li 28:34 Sure. Taking care of yourself. At the end of the day, it's a marathon.
Sonia Prashar 28:38 It is a marathon. And if you're not not really aligned with yourself, you can lose yourself. And so ten years ago, I didn't know what I know today, of course, that it's just a cycle. And taking get lost in this whole gamut of cat and mouse game.
Brandon Li 28:58 Absolutely. It's funny you you say that. Of course, I get asked a a flavor of the the same question, and I think a lot of entrepreneurs will kinda echo that when you're just starting, it feels like taking the leap is the hardest part, but you don't actually realize how hard it is to keep it running. 28:58] Brandon Li: Absolutely. It's funny you you say that. Of course, I get asked a a flavor of the the same question, and I think a lot of entrepreneurs will kinda echo that when you're just starting, it feels like taking the leap is the hardest part, but you don't actually realize how hard it is to keep it running.
Sonia Prashar 29:13 I forgot, um, the name of the actor in Bohemian Rhapsody, the guy who won the Oscar, Alek or something. It was I think it was his interview where he said, this is now where the hard work actually starts. Because once you have achieved something, you have to keep going. You have no other choice, and that becomes so difficult sometimes because there are days you and I both know we don't we want to get up and we wanna go back to sleep. We don't wanna take the red eye. We don't, but we do it because we're passionate for it. The people don't realize the sacrifices that go behind it. And that ten years ago, I didn't know that it would be this hard, but I think it's important to keep self mental health in check and forgive yourself. It's okay.
Brandon Li 30:01 There will be lows, but there will also be highs.
Sonia Prashar 30:05 There will be highs. There'll be small wins also coming through. In fact, yesterday, I was talking to one of our psychiatrists. You know, he said, Sonia, two years ago, that person you were, you're not today.
Brandon Li 30:18 That's, uh, I I hope that was a compliment.
Sonia Prashar 30:21 Yeah. Yeah. It was. And he's like, people will gossip because we were talking in terms of some gossip around, but those people are always gonna be where they were. And they are again, two years later also, they're gonna be there where they were just gossiping about somebody else. You've continued to move forward. So it's okay to forgive because this won't be your first mistake. It won't be your last mistake. You're going to continue to make mistakes, and just learn to forgive yourself.
Brandon Li 30:48 The thing that I find myself kind of reminding myself a lot, and I don't know if this is, uh, familiar to you, but it's that everything is always hardest the first time. The challenge with running a business is that, like, there's always a next first time. You don't get to just solve the same problem every day.
Sonia Prashar 31:03 I completely agree with you. It's always a new muscle that we realize, oh my god. We have to train that one now.
Brandon Li 31:08 But the thing that was difficult two years ago now feels really easy, and that's a beautiful thing.
Sonia Prashar 31:12 I completely agree. And, you know, forgiving yourself, keep yourself in check, it's okay.
Brandon Li 31:17 This has been so fun. What do you not get asked often enough that you wish you were asked more? at was difficult two years ago now feels really easy, and that's a beautiful thing.
Sonia Prashar 31:12 I completely agree. And, you know, forgiving yourself, keep yourself in check, it's okay.
Brandon Li 31:17 This has been so fun. What do you not get asked often enough that you wish you were asked more?
Sonia Prashar 31:24 For me, personally, I think what people don't ask is I mean, there's always something or the other that's always new. Like you just said, you know, it's more or less about people don't ask about or talk about the sacrifices that went along the way. People always ask about the wins. Nobody asks about the failures. And I wish people asked about those failures more because their actual lesson happened in those failures. I wish people talk about that. And more importantly, what I always tell people is that don't focus on what the person's achieved because it's easy to say, oh, wow. You know you're rich. You or you are driving this car. You live in a penthouse. Oh, you're flying to, uh, you're staying at this resort. It's it's easy to judge. Talk about that hard work, the hard work that went along with it. Talk about that. And nobody wants to talk about the hard stuff.
Brandon Li 32:22 It's certainly not fun at conferences.
Sonia Prashar 32:24 No. Um, usually, one of those, you know, I mean, you know that. Everybody, I think, who knows me knows I'm the vocal. I'm also the jester.
Brandon Li 32:33 Well, some combination of that is delightful.
Sonia Prashar 32:35 So, you know, it's entertaining as well, but it's people I wish they asked more about the failures, not so much just about Goobens.
Brandon Li 32:42 Well, uh, the next time we catch up over a coffee or something, uh, we'll have to talk about some of those failures because, uh, certainly some hard won lessons.
Sonia Prashar 32:49 Those are the hard lessons, and those are the ones that teach you. Like, one of my hardest lessons I learned how to drive in this country was a broken leg. It started with a broken leg, having forced to start driving to go to doctor's office and third degree fracture.
Brandon Li 33:06 Oh, no. That sounds stressful.
Sonia Prashar 33:09 If it wasn't for that hard day hard day, hard moment, I wouldn't have been forced to drive.
Brandon Li 33:13 And without without that, you would not be here today.
Sonia Prashar 33:16 That is true. The moral of the story is it's okay. Do not be afraid of the hard lessons.
Brandon Li 33:21 Do not be afraid of the hard things. Well, Sonya, I've I so enjoyed this conversation. I really appreciate you taking the time to get on the phone, share some of your lessons, share some
Sonia Prashar 33:31 of your wisdom in building
Brandon Li 33:34 in trials. Thank you so much, Brandon. It's definitely a pleasure. Likewise.